🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This efficacy and safety study compares four different combinations of blin...
Status
Completed
Location
1249.1.32003 Boehringer Ingelheim Investigational Site
Start Date
2007-10
Trial ID
NCT00535366
Treatments Being Tested
Stage 1 of the study is designed to provide data about the risk-benefit of ...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2007-04
Trial ID
NCT00463567
To demonstrate superiority of QVA149 (110/50 μg) once daily compared to tio...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-03-23
Trial ID
NCT02566031
Treatments Being Tested
This is a multi-center, randomized, double-blind, parallel group, chronic d...
Status
Completed
Location
Pearl Investigative Site
Start Date
2013-11
Trial ID
NCT01970878
The primary objective of this study is to assess the efficacy of Glycopyrro...
Status
Completed
Location
Pearl Investigative Site
Start Date
2012-04
Trial ID
NCT01587079
Treatments Being Tested
This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-03
Trial ID
NCT00846586
Treatments Being Tested
Study to evaluate the pharmacokinetics of tiotropium following 14 days of a...
Status
Completed
Location
Multiple Locations
Start Date
1998-02
Trial ID
NCT02172326
Treatments Being Tested
The primary objective of this study is to demonstrate the superiority of ti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02203474
Treatments Being Tested
This study was designed to investigate the 1 year efficacy and safety of th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-06
Trial ID
NCT00929110
Treatments Being Tested
This is a 52-week, multi-center, randomized, open label, parallel group stu...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-05
Trial ID
NCT01119937
Treatments Being Tested